DK120079B - Analogifremgangsmåde til fremstilling af 3-(2'-R- eller 2'-S-tetrahydropyranyloxy)- Δ<1,3,5(10)>-estratriener. - Google Patents

Analogifremgangsmåde til fremstilling af 3-(2'-R- eller 2'-S-tetrahydropyranyloxy)- Δ<1,3,5(10)>-estratriener.

Info

Publication number
DK120079B
DK120079B DK638366A DK638366A DK120079B DK 120079 B DK120079 B DK 120079B DK 638366 A DK638366 A DK 638366A DK 638366 A DK638366 A DK 638366A DK 120079 B DK120079 B DK 120079B
Authority
DK
Denmark
Prior art keywords
estratrienes
tetrahydropyranyloxy
preparation
analogous process
analogous
Prior art date
Application number
DK638366A
Other languages
English (en)
Inventor
Ruggieri P De
C Gandolfi
U Guzzi
Original Assignee
Ormonoterapia Richter Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ormonoterapia Richter Spa filed Critical Ormonoterapia Richter Spa
Publication of DK120079B publication Critical patent/DK120079B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK638366A 1966-10-03 1966-12-09 Analogifremgangsmåde til fremstilling af 3-(2'-R- eller 2'-S-tetrahydropyranyloxy)- Δ<1,3,5(10)>-estratriener. DK120079B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2843666 1966-10-03

Publications (1)

Publication Number Publication Date
DK120079B true DK120079B (da) 1971-04-05

Family

ID=11223598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK638366A DK120079B (da) 1966-10-03 1966-12-09 Analogifremgangsmåde til fremstilling af 3-(2'-R- eller 2'-S-tetrahydropyranyloxy)- Δ<1,3,5(10)>-estratriener.

Country Status (4)

Country Link
DK (1) DK120079B (da)
FR (3) FR1505056A (da)
NL (1) NL6617400A (da)
SE (2) SE366029B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518255A (en) * 1967-07-07 1970-06-30 Erba Carlo Spa Acetalic ethers of estra-1,3,5(10)-trienes and process for their preparation

Also Published As

Publication number Publication date
SE339686B (da) 1971-10-18
FR7824M (da) 1970-05-25
DE1593225A1 (de) 1972-04-20
FR1505056A (fr) 1967-12-08
NL6617400A (da) 1968-04-04
SE366029B (da) 1974-04-08
DE1593225B2 (de) 1975-07-17
FR7823M (da) 1970-05-25

Similar Documents

Publication Publication Date Title
DK125553B (da) Fremgangsmåde til fremstilling af substituerede 2,4-diamino-5-benzylpyrimidiner.
DK111956B (da) Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ&lt;9&gt;-estren.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK129234B (da) Fremgangsmåde til fremstilling af levo-1-n-butyl-2&#39;,6&#39;-pipecoloxylidid.
DK116656B (da) Analogifremgangsmåde til fremstilling af 11-oxygenerede 3-(2&#39;-chlorethylthio)-6-formyl-9α-fluor-3,5-pregnadien-20-oner.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK114972B (da) Fremgangsmåde til fremstilling af 4-halogen-1,2α; 6,7β-bismethylen-Δ&lt;4&gt;-3-ketosteroider.
DK114556B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-2-on-4-oxider.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK120079B (da) Analogifremgangsmåde til fremstilling af 3-(2&#39;-R- eller 2&#39;-S-tetrahydropyranyloxy)- Δ&lt;1,3,5(10)&gt;-estratriener.
DK114962B (da) Fremgangsmåde til fremstilling af α, α, α&#39;, α&#39;-tetramethyl-xylylen-dicarbinoler.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ&lt;4,8(14),9&gt;-gonatriener.
DK117420B (da) Analogifremgangsmåde til fremstilling af 12-oxygeneret-Δ&lt;3&gt;-A-norandrosten-2,17-dion.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N&lt;4&gt;-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK124204B (da) Analogifremgangsmåde til fremstilling af derivater af 3-phenyl-2-oxo-4-thion- eller 3-phenyl-2,4-dithion-dihydrobenzoxaziner-(1,3).
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK116735B (da) Fremgangsmåde til fremstilling af Δ&lt;14&gt;-pregnen-3,21-diol-20-on-21-acylater.
DK109329C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-6α-alkyl-19-nor-pregnener.
DK111681B (da) Fremgangsmåde til fremstilling af 3-(2&#39;-chlorethoxy)-17α-ethynyl-17β-hydroxy-Δ&lt;1,3,5(10)&gt;-østratrien.
DK116941B (da) Fremgangsmåde til fremstilling af 6-klor-Δ&lt;4,6&gt;-pregnadiener.
DK114205B (da) Analogifremgangsmåde til fremstilling af 4-acetyl-5-acetylimino-1-metyl-3-(5-nitro-2-furyl)-Δ&lt;2&gt;-1,2,4-triazolin.